Loading comparison

Arzeda vs Dyno Therapeutics

Computational de novo protein and enzyme design company spun out of David Baker's University of Washington lab.

Uses AI to engineer AAV capsids as improved gene-delivery vectors, licensing designs to major pharma.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →